Making milestones: The evolving treatment landscape in LA/mUC (ID 6085)
Discovering the data: MoA and core clinical evidence (ID 6086)
Defining the direction: Enfortumab vedotin eligibility and treatment initiation (ID 6087)
Practical tips for treatment: Optimising outcomes and managing adverse events (ID 6088)
Prioritising patients in practice: Evidence-driven care in the clinic (ID 6089)
Pinpoints of interest: Panel discussion and Q&A (ID 6090)
